bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell Lymphoma
- 20 April 1989
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (16) , 1047-1054
- https://doi.org/10.1056/nejm198904203201605
Abstract
Approximately half the patients with diffuse or follicular large-cell or mixed large- and small-cell lymphoma enter a prolonged remission or are cured after receiving combined-drug therapy. It has been unclear, however, why the other half do not respond.This publication has 17 references indexed in Scilit:
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activityNature, 1987
- DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene.Proceedings of the National Academy of Sciences, 1987
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987
- Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACODAnnals of Internal Medicine, 1986
- Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanomaSomatic Cell and Molecular Genetics, 1985
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984
- Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphomaCancer Genetics and Cytogenetics, 1984
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1982
- Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genesCell, 1981